Covered recipient · General Payments record
VICKY BROOKS
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$2,064.33
- Reported across 78 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $755.64 | 29 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $172.12 | 8 |
| Acerta Pharma LLC | $169.89 | 4 |
| Amgen Inc. | $140.45 | 5 |
| PFIZER INC. | $90.44 | 4 |
| Abbott Laboratories | $49.33 | 2 |
| Novo Nordisk AS | $47.14 | 2 |
| Exact Sciences Corporation | $28.50 | 1 |
| Sumitomo Pharma America, Inc. | $23.11 | 1 |
| GlaxoSmithKline, LLC. | $18.47 | 1 |
| Currax Pharmaceuticals LLC | $16.19 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (29)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $25.96 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124995907 | CMS |
| Abbott Laboratories | $23.37 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124995909 | CMS |
| ABBVIE INC. | $17.53 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106829532 | CMS |
| ABBVIE INC. | $18.22 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106829534 | CMS |
| ABBVIE INC. | $30.91 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106829536 | CMS |
| ABBVIE INC. | $25.41 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106829538 | CMS |
| ABBVIE INC. | $23.43 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106829540 | CMS |
| ABBVIE INC. | $17.84 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106829542 | CMS |
| ABBVIE INC. | $22.57 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106829544 | CMS |
| ABBVIE INC. | $16.21 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106829546 | CMS |
| Amgen Inc. | $9.69 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117514581 | CMS |
| Amgen Inc. | $13.68 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117210540 | CMS |
| Amgen Inc. | $90.34 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117210544 | CMS |
| Amgen Inc. | $14.17 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117514583 | CMS |
| Amgen Inc. | $12.57 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117210542 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.57 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104209431 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.43 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105466467 | CMS |
| AstraZeneca Pharmaceuticals LP | $48.16 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104541602 | CMS |
| AstraZeneca Pharmaceuticals LP | $90.73 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105760313 | CMS |
| Currax Pharmaceuticals LLC | $16.19 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089525756 | CMS |
| Exact Sciences Corporation | $28.50 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114599978 | CMS |
| GlaxoSmithKline, LLC. | $18.47 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116312305 | CMS |
| Novo Nordisk Inc | $22.61 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100321254 | CMS |
| Novo Nordisk Inc | $24.53 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100504037 | CMS |
| PFIZER INC. | $22.68 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131025968 | CMS |
| PFIZER INC. | $19.75 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131256408 | CMS |
| PFIZER INC. | $15.33 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131509377 | CMS |
| PFIZER INC. | $32.68 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131056975 | CMS |
| Sumitomo Pharma America, Inc. | $23.11 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148947023 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.